共 104 条
[1]
Koedel U(2002)Pathogenesis and pathophysiology of pneumococcal meningitis Lancet Infect Dis 2 721-36
[2]
Scheld WM(2002)Matrix metalloproteinases in neuroinflammation Glia 39 279-91
[3]
Pfister HW(1998)Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis Ann Neurol 44 592-600
[4]
Rosenberg GA(2000)Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae Clin Infect Dis 31 80-4
[5]
Paul R(1996)Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy Infect Immun 64 4883-90
[6]
Lorenzl S(2012)Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis Antimicrob Agents Chemother 56 4289-95
[7]
Koedel U(2014)Endogenous and synthetic MMP inhibitors in CNS physiopathology Prog Brain Res 214 313-51
[8]
Sporer B(1999)Design and therapeutic application of matrix metalloproteinase inhibitors Chem Rev 99 2735-76
[9]
Vogel U(2001)Matrix metalloproteinase inhibitors in rheumatic diseases Ann Rheum Dis 60 iii62-7
[10]
Frosch M(1999)Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors Nat Struct Biol 6 217-21